|
1
|
Epidemiology, pathology, and pathogenesis
of renal cell carcinoma. UpToDate. 2020.
|
|
2
|
Hsieh JJ, Purdue MP, Signoretti S, Swanton
C, Albiges L, Schmidinger M, Heng DY, Larkin J and Ficarra V: Renal
cell carcinoma. Nat Rev Dis Primers. 3:170092017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lopez-Beltran A, Carrasco JC, Cheng L,
Scarpelli M, Kirkali Z and Montironi R: 2009 update on the
classification of renal epithelial tumors in adults. Int J Urol.
16:432–443. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zheng J: Energy metabolism of cancer:
Glycolysis versus oxidative phosphorylation (Review). Oncol Lett.
4:1151–1157. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Favaro E, Lord S, Harris AL and Buffa FM:
Gene expression and hypoxia in breast cancer. Genome Med. 3:552011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li W, Qiu Y, Hao J, Zhao C, Deng X and Shu
G: Dauricine upregulates the chemosensitivity of hepatocellular
carcinoma cells: Role of repressing glycolysis via
miR-199a:HK2/PKM2 modulation. Food Chem Toxicol. 121:156–165. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang Y, Lin D and Taniguchi CM: Hypoxia
inducible factor (HIF) in the tumor microenvironment: Friend or
foe? Sci China Life Sci. 60:1114–1124. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McKeown SR: Defining normoxia, physoxia
and hypoxia in tumours-implications for treatment response. Br J
Radiol. 87:201306762014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chilov D, Camenisch G, Kvietikova I,
Ziegler U, Gassmann M and Wenger RH: Induction and nuclear
translocation of hypoxia-inducible factor-1 (HIF-1):
Heterodimerization with ARNT is not necessary for nuclear
accumulation of HIF-1alpha. J Cell Sci. 112:1203–1212.
1999.PubMed/NCBI
|
|
11
|
Mandl M and Depping R: Hypoxia-inducible
aryl hydrocarbon receptor nuclear translocator (ARNT) (HIF-1β): Is
it a rare exception? Mol Med. 20:215–220. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Abel J and Haarmann-Stemmann T: An
introduction to the molecular basics of aryl hydrocarbon receptor
biology. Biol Chem. 391:1235–1248. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zagórska A and Dulak J: HIF-1: The knowns
and unknowns of hypoxia sensing. Acta Biochim Pol. 51:563–585.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gunton JE, Kulkarni RN, Yim S, Okada T,
Hawthorne WJ, Tseng YH, Roberson RS, Ricordi C, OConnell PJ,
Gonzalez FJ and Kahn CR: Loss of ARNT/HIF1beta mediates altered
gene expression and pancreatic-islet dysfunction in human type 2
diabetes. Cell. 122:337–349. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
da Silva Xavier G, Rutter J and Rutter GA:
Involvement of Per-Arnt-Sim (PAS) kinase in the stimulation of
preproinsulin and pancreatic duodenum homeobox 1 gene expression by
glucose. Proc Natl Acad Sci USA. 101:8319–8324. 2004. View Article : Google Scholar
|
|
16
|
Levisetti MG and Polonsky KS: Diabetic
pancreatic beta cells ARNT all they should be. Cell Metab. 2:78–80.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fernandez-Salguero PM, Ward JM, Sundberg
JP and Gonzalez FJ: Lesions of aryl-hydrocarbon receptor-deficient
mice. Vet Pathol. 34:605–614. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang Q, Sun Y, Ma X, Gao Y, Li X, Niu Y,
Zhang X and Chang C: Androgen receptor increases hematogenous
metastasis yet decreases lymphatic metastasis of renal cell
carcinoma. Nat Commun. 8:9182017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ju L, Zhang X, Deng Y, Han J, Yang J, Chen
S, Fang Q, Yang Y and Jia W: Enhanced expression of survivin has
distinct roles in adipocyte homeostasis. Cell Death Dis.
8:e25332017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Escudier B, Eisen T, Stadler WM, Szczylik
C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA,
et al: Sorafenib in advanced clear-cell renal-cell carcinoma. N
Engl J Med. 356:125–134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wilhelm SM, Carter C, Tang L, Wilkie D,
McNabola A, Rong H, Chen C, Zhang X, Vincent P, McHugh M, et al:
BAY 43-9006 exhibits broad spectrum oral antitumor activity and
targets the RAF/MEK/ERK pathway and receptor tyrosine kinases
involved in tumor progression and angiogenesis. Cancer Res.
64:7099–7109. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rankin EB and Giaccia AJ: The role of
hypoxia-inducible factors in tumorigenesis. Cell Death Differ.
15:678–685. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang GL, Jiang BH, Rue EA and Semenza GL:
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS
heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci
USA. 92:5510–5514. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vavilala DT, Ponnaluri VK, Vadlapatla RK,
Pal D, Mitra AK and Mukherji M: Honokiol inhibits HIF pathway and
hypoxia-induced expression of histone lysine demethylases. Biochem
Biophys Res Commun. 422:369–374. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mandl M, Kapeller B, Lieber R and Macfelda
K: Hypoxia-inducible factor-1β (HIF-1β) is upregulated in a
HIF-1α-dependent manner in 518A2 human melanoma cells under hypoxic
conditions. Biochem Biophys Res Commun. 434:166–172. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guidelines for the diagnosis and treatment
of renal cancer. National Health Commission of the Peoples Republic
of China. 2018.
|
|
27
|
Zelzer E, Levy Y, Kahana C, Shilo BZ,
Rubinstein M and Cohen B: Insulin induces transcription of target
genes through the hypoxia-inducible factor HIF-1alpha/ARNT. EMBO J.
17:5085–5094. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Salceda S, Beck I and Caro J: Absolute
requirement of aryl hydrocarbon receptor nuclear translocator
protein for gene activation by hypoxia. Arch Biochem Biophys.
334:389–394. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Forsythe JA, Jiang BH, Iyer NV, Agani F,
Leung SW, Koos RD and Semenza GL: Activation of vascular
endothelial growth factor gene transcription by hypoxia-inducible
factor 1. Mol Cell Biol. 16:4604–4613. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Okino ST, Chichester CH and Whitlock JP
Jr: Hypoxia-inducible mammalian gene expression analyzed in vivo at
a TATA-driven promoter and at an initiator-driven promoter. J Biol
Chem. 273:23837–23843. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bratslavsky G, Sudarshan S, Neckers L and
Linehan WM: Pseudohypoxic pathways in renal cell carcinoma. Clin
Cancer Res. 13:4667–4671. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Myszczyszyn A, Czarnecka AM, Matak D,
Szymanski L, Lian F, Kornakiewicz A, Bartnik E, Kukwa W, Kieda C
and Szczylik C: The role of hypoxia and cancer stem cells in renal
cell carcinoma pathogenesis. Stem Cell Rev Rep. 11:919–943. 2015.
View Article : Google Scholar : PubMed/NCBI
|
